Article List

WPRIM Management System> DCMS> The Korean Journal of Hepatology> 2010> 16> 4

Volume: 16 Issue: 4

1. Which treatment modality should we choose for advanced hepatocellular carcinoma?.	Page:353—354
2. Hemodynamic alterations in cirrhosis and portal hypertension.	Page:347—352
3. Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea.	Page:362—368
4. Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis.	Page:369—375
5. Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma.	Page:389—396
6. Sigmoid colon metastasis from hepatocellular carcinoma.	Page:397—400
7. Hepatogastric fistula caused by direct invasion of hepatocellular carcinoma after transarterial chemoembolization and radiotherapy.	Page:401—404
8. A case of hepatocellular carcinoma in the caudate lobe successfully treated by transcatheter arterial chemoembolization using drug-eluting beads.	Page:405—409
9. Sclerosed hemangioma of the liver.	Page:410—413
10. Focal nodular hyperplasia: with a focus on contrast enhanced ultrasound.	Page:414—417
11. The effect of sorafenib on hepatic stellate cells: implication of its effect on tumor microenvironment.	Page:418—419
12. A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma.	Page:355—361
13. Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis.	Page:376—382
14. Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma.	Page:383—388